Literature DB >> 2440144

A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).

N Odum, B Hofmann, J J Hyldig-Nielsen, B K Jakobsen, N Morling, P Platz, L P Ryder, A Svejgaard.   

Abstract

Primed Lymphocyte Typing (PLT) with local (CDP) and the 9th International Histocompatibility Workshop reagents (GNN) revealed "cross-reactions" between HLA-DPw6 and the GNN2B but not other DPw2 PLT-cells (GNN2A, CDP2A, CDP2B). We raised and bulk-expanded a well discriminating PLT-reagent (the JET-reagent) from an HLA-DR identical, DP, GNN2A, CDP2A, CDP2B compatible and GNN2B incompatible responder/stimulator combination. The JET-reagent defined a "new" determinant, JET, which was present in 11% of Danes. The JET determinant was associated with DPw2, w6, and DP-blank: 66% of DPw6 and DP-blank and 20% of DPw2-positive individuals were JET-positive. All JET-positive individuals belonged to this group, and six of these had two DP-antigens. JET segregated with DP-blank in three and with DPw6 in two informative families. In an HLA-DR/DPw6 recombinant family, JET segregated with DPw6 in the recombinant haplotype. The JET PLT-responses against all of six different JET-positive stimulators including the specific stimulator were strongly inhibited by the monoclonal antibody (MoAb) Tü39, which preferentially reacts with DP-molecules, but not by other HLA-specific MoAbs. The results indicate that JET is either a "new" supertypic DP-related specificity or a determinant, which shares epitopes with DP, of a "new" locus and in linkage disequilibrium with DP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440144     DOI: 10.1111/j.1399-0039.1987.tb01558.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.

Authors:  N Odum; N Morling; P Platz; B Hofmann; L P Ryder; C Heilmann; F K Pedersen; L P Nielsen; J Friis; A Svejgaard
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

2.  Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes.

Authors:  T L Bugawan; A B Begovich; H A Erlich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.

Authors:  H S de Koster; M J Kenter; J D'Amaro; R M Luiten; W E Schroeijers; M J Giphart; A Termijtelen
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Typing for HLA-DPB1*03 and HLA-DPB1*06 using allele-specific DNA in vitro amplification and allele-specific oligonucleotide probes. Detection of "new" DPB1*06 variants.

Authors:  L Fugger; N Morling; L P Ryder; N Odum; J Georgsen; A Svejgaard
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.